ICA07
/ iCamuno Biotherapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 12, 2025
Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: iCamuno Biotherapeutics Ltd.
New P1 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 1
Of
1
Go to page
1